Cases & Deals

  • Home
  • Practices
  • Cibus completes $22.6 million registered direct offering of Common Stock, pre-funded warrants, and accompanying Common Warrants

Share

Cibus completes $22.6 million registered direct offering of Common Stock, pre-funded warrants, and accompanying Common Warrants

January 2025

Client(s) Cibus, Inc.

Jones Day represented Cibus, Inc. in connection with its registered direct offering of 4,340,000 shares of its Class A Common Stock accompanying Common Warrants to purchase an aggregate of 4,340,000 shares of its Class A Common Stock and pre-funded warrants to purchase 4,700,000 shares of Class A Common Stock and accompanying Common Warrants to purchase up to an aggregate of 4,700,000 shares of its Class A Common Stock for an aggregate purchase price of approximately $22.6 million.

Cibus, Inc. (NASDAQ: CBUS) is a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.